Xyratex Reiterated at Hold and 3 Analyst-Reiterated Ratings to Track

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on September 28th.

Biomarin Pharm (NASDAQ:BMRN): Summer Street Research reiterated its rating of Buy for this company and changed its price target from $45 to $52.

Accenture (NYSE:ACN): Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $76 to $79.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Xyratex (NASDAQ:XRTX): Cantor Fitzgerald reiterated its rating of Hold for this company and changed its price target from $11.5 to $10.5.

American Science & Engineering (NASDAQ:ASEI): The Benchmark Company reiterated its rating of Buy for this company and changed its price target from $58 to $73.

Don’t Miss: Caterpillar Outlook: Hidden Signal for Higher Gold and Silver Prices?